Clinical Trial: Bonefos and the Consumption of Analgesics
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Bonefos and the Consumption of Analgesics. Influence of Clodronate on Analgesics Consumption Among Patients With Bone Metastasis
Brief Summary: The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.
Detailed Summary:
Sponsor: Bayer
Current Primary Outcome: Analgesics consumption after 12 months of treatment with Bonefos in patients with bone metastases and breast or prostate cancer or multiple myeloma [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Decrease in pain measured by VAS (Visual Analogue Scale) [ Time Frame: 12 months ]
Original Secondary Outcome: Same as current
Information By: Bayer
Dates:
Date Received: May 25, 2009
Date Started: April 2007
Date Completion:
Last Updated: April 5, 2012
Last Verified: April 2012